Mature Cataracts with Rheumatoid Peripheral Ulcerative Keratitis Treated by One- and Left-Handed Surgery via the Inferior Nasal Site

经鼻下入路单手左手手术治疗伴有类风湿性周围溃疡性角膜炎的成熟期白内障

阅读:1

Abstract

PURPOSE: To apply one- and left-handed phacoemulsification from the inferior nasal site for a case of rheumatoid peripheral ulcerative keratitis complicated by peripheral corneal thinning, which presented difficulties for standard two-handed cataract surgery. METHODS: A case report. RESULTS: The patient was an 80-year-old Japanese woman with the progression of peripheral ulcerative keratitis in the periphery of both eyes and a history of rheumatoid arthritis. Both eyes exhibited peripheral ulcerative keratitis, with the right eye particularly affected around the entire circumference of the cornea, except for the inferior nasal site. The disease subsided with the use of soft contact lenses and betamethasone and cyclosporine administration. The cataract progressed to a mature stage, and the density of corneal endothelial cells decreased to approximately 600/mm(2). A right-handed surgeon, positioned at the lower left corner of her face, performed phacoemulsification using a one- and left-handed technique, without performing paracentesis, through a sclerocorneal incision from the inferior nasal site of her right eye. Postoperatively, her best-corrected visual acuity improved to 20/25 from hand motion. CONCLUSIONS: A patient with almost total circumferential thinning of the cornea, which appeared to be a challenge for standard cataract surgery, could undergo successful cataract surgery with the selection of an appropriate incision site and technique. The findings of this case report may provide valuable insights for the development of safe surgical strategies for cataract surgery in cases characterized by severe, almost circumferential peripheral thinning of the cornea.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。